Literature DB >> 7795103

Geographic latitude and the efficacy of bacillus Calmette-Guérin vaccine.

M E Wilson1, H V Fineberg, G A Colditz.   

Abstract

In a meta-analysis of the efficacy of BCG vaccine for preventing tuberculosis, study sites at a greater distance from the equator were associated with a higher efficacy. In a random-effects regression analysis of prospective studies, geographic latitude alone accounted for 41% of the between-study variance. Many factors that vary with latitude may influence the effectiveness of BCG vaccine by modifying the susceptibility of human hosts, the pathogenecity of the organism, or host-agent interactions. These factors include socioeconomic conditions, genetic composition of the population, climate, exposure to sunlight, diet and nutrition, presence of nontuberculous mycobacteria in the environment, completeness of surveillance and follow-up in studies of BCG vaccine, virulence of locally prevalent strains of Mycobacterium tuberculosis, and storage and viability of BCG vaccine. This paper describes the biological plausibility, epidemiologic evidence, and other scientific data bearing on the influence of these factors on the efficacy of BCG vaccine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7795103     DOI: 10.1093/clinids/20.4.982

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  22 in total

Review 1.  Cofactors that may influence vaccine responses.

Authors:  Guy de Bruyn
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

Review 2.  Interplay between innate and adaptive immunity in the development of non-infectious uveitis.

Authors:  François Willermain; James T Rosenbaum; Bahram Bodaghi; Holly L Rosenzweig; Sarah Childers; Travis Behrend; Gerhild Wildner; Andrew D Dick
Journal:  Prog Retin Eye Res       Date:  2011-11-22       Impact factor: 21.198

Review 3.  The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guérin (BCG) vaccines: is there a link?

Authors:  F Abebe; G Bjune
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

4.  The use of Bacille Calmette-Guérin vaccination in children.

Authors:  D P Speert
Journal:  Can J Infect Dis       Date:  1995-09

Review 5.  Vaccines for tuberculosis: novel concepts and recent progress.

Authors:  T Mark Doherty; Peter Andersen
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

6.  A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements.

Authors:  L Wang; M O Turner; R K Elwood; M Schulzer; J M FitzGerald
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

7.  Immunological consequences of intragenus conservation of Mycobacterium tuberculosis T-cell epitopes.

Authors:  Cecilia S Lindestam Arlehamn; Sinu Paul; Federico Mele; Charlie Huang; Jason A Greenbaum; Randi Vita; John Sidney; Bjoern Peters; Federica Sallusto; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-29       Impact factor: 11.205

8.  Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses.

Authors:  Anna M Checkley; David H Wyllie; Thomas J Scriba; Tanya Golubchik; Adrian V S Hill; Willem A Hanekom; Helen McShane
Journal:  PLoS One       Date:  2011-10-25       Impact factor: 3.240

9.  Latent tuberculosis infection, tuberculin skin test and vitamin D status in contacts of tuberculosis patients: a cross-sectional and case-control study.

Authors:  Alberto Arnedo-Pena; José Vicente Juan-Cerdán; Angeles Romeu-Garcia; Daniel Garcia-Ferrer; Rita Holguín-Gómez; Jesús Iborra-Millet; Concepción Herrero-Carot; María Jesús Sanchis Piñana; Juan Bellido-Blasco; José Antonio Ferrero-Vega; Lourdes Safont Adsuara; Esther Silvestre Silvestre; Noemi Meseguer Ferrer; Vicenta Rodrigo Bartual
Journal:  BMC Infect Dis       Date:  2011-12-15       Impact factor: 3.090

10.  Placental malaria is associated with attenuated CD4 T-cell responses to tuberculin PPD 12 months after BCG vaccination.

Authors:  Brigitte Walther; David J C Miles; Pauline Waight; Melba S Palmero; Olubukola Ojuola; Ebrima S Touray; Hilton Whittle; Marianne van der Sande; Sarah Crozier; Katie L Flanagan
Journal:  BMC Infect Dis       Date:  2012-01-14       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.